Bell Investment Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Bell Investment Advisors's BMY Position: Q1 2026 in Review
Bell Investment Advisors increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $4.66K and bringing the position to 542 shares worth $32.9K. The position accounts for 0.01% of the portfolio, ranked #328.
Bell Investment Advisors first reported a position in BMY in Q3 2021 and has held it in 18 quarters since. The position peaked at $94K in Q2 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bell Investment Advisors held 542 shares of Bristol-Myers Squibb worth $32.9K as of Q1 2026.
- Bell Investment Advisors bought 80 Bristol-Myers Squibb shares in Q1 2026, an estimated $4.66K.
- Bristol-Myers Squibb made up 0.01% of Bell Investment Advisors's portfolio in Q1 2026, its #328 holding.
- Bell Investment Advisors first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 18 quarters since.
- Bell Investment Advisors's Bristol-Myers Squibb position peaked at $94K in Q2 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bell Investment Advisors's 13F filing for Q1 2026, filed 17 Apr 2026.